A specialized research center at The University of Texas Medical Branch at Galveston that helps older adults has received a $6.3 million renewal of its grant from the National Institute on Aging. The Claude D. Pepper Older Americans Independence Center at UTMB has been continually funded since 2000.

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered a Zika virus mutation that may be responsible for the explosive viral transmission in 2015/2016 and for the cause of microcephaly (babies with small heads) born to infected pregnant women. The study is currently available in Proceedings of National Academy of Sciences.

How did Zika virus acquire the ability to infect the brain and reproductive tissue to cause its characteristic disease? The answer may lie in a newly observed ability of the virus to use a host cell’s own defense mechanisms as a disguise. A team from The University of Texas Medical Branch at Galveston have published new research that shows the Zika virus evolved to use a host cellular enzyme for its own invasion, potentially explaining the mechanism by which the virus efficiently infects the brain and reproductive tissues, a potential explanation for how the Zika virus causes congenital neurological disorders like microcephaly, found in the newborns of infected mothers.

A multidisciplinary team from The University of Texas Medical Branch at Galveston has uncovered a new mechanism for designing antiviral drugs for dengue virus.

Researchers from The University of Texas Medical Branch at Galveston have received more than $7.7 million from the National Institute of Allergy & Infectious Diseases to spearhead a Center to identify, track and counter mosquito-borne diseases.

A team of researchers from The University of Texas Medical Branch at Galveston, led by Dr. George Saade, are active partners in the National Institutes of Health’s newly launched study to learn more about the impact of the COVID-19 pandemic on pregnancy and post-partum care.

A multidisciplinary team at The University of Texas Medical Branch at Galveston working to combat the COVID-19 virus has a system that will unlock researchers’ ability to more quickly develop and evaluate developing vaccines, diagnose infected patients and explore whether or how the virus has evolved.

Researchers at The University of Texas Medical Branch are collaborating with the clinical trial laboratory services organization Q2 Solutions to make a new assay test available that will streamline the development of a COVID-19 vaccine.